2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9833449
SERIAL NO

15352340

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXO GROUP LIMITEDSTEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Atkinson, Stephen John Stevenage, GB 27 60
Barker, Michael David Stevenage, GB 25 190
Campbell, Matthew Stevenage, GB 65 301
Diallo, Hawa Stevenage, GB 6 6
Douault, Clement Stevenage, GB 8 11
Garton, Neil Stuart Stevenage, GB 10 85
Liddle, John Stevenage, GB 57 129
Sheppard, Robert John Stevenage, GB 14 17
Walker, Ann Louise Stevenage, GB 45 314
Wellaway, Christopher Stevenage, GB 4 5
Wilson, David Matthew Stevenage, GB 52 269

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00